BRIEF-CME Group CEO on CNBC - Some parts of Dodd-Frank don't need to be changed

* CME Group CEO Terry Duffy on CNBC - Some parts of

Dodd-Frank don't need to be changed

Read more

UPDATE 1-EU set to approve ChemChina's $43 bln bid for Syngenta - sources

BRUSSELS, Feb 2 (Reuters) - ChemChina is set to

secure conditional EU antitrust approval for its $43 billion bid

for Swiss pesticides and seeds group Syngenta, the

largest foreign acquisition by a...

Read more

BRIEF-Amir Efrati reports 7.5 pct stake in Alcobra Ltd as of Jan. 23

* Amir Efrati reports 7.5 percent stake in Alcobra Ltd as of

January 23 - sec filing

Read more

BRIEF-Metlife investment portollo starting to benefit from higher interest rates, ceo says

* Investment portollo starting to benefit from higher

interest rates, ceo says

Read more

UPDATE 1-British Brexit paper stresses hope for mutual EU/UK benefit

LONDON, Feb 2 (Reuters) - Britain will do its utmost to

negotiate a divorce deal with the European Union that is

mutually beneficial, Brexit minister David Davis said on

Thursday, setting out the...

Read more

BRIEF-Teva confirms generic Victoza patent challenge in the United States

* Teva confirms generic Victoza patent challenge in the

united states

Read more

BRIEF-Cytomx announces the first patient treated in phase 1/2 proclaim-072 trial

* Cytomx announces the first patient treated in phase 1/2

proclaim-072 trial

Source text for Eikon:

Further company coverage:

Read more